Ophthalmic Pharmacology Practice Questions

Q: Timolol is preferred in glaucoma over pilocarpine because:

It produces fewer ocular side effects. **Explanation:** The preference for **Timolol** (a non-selective beta-blocker) over **Pilocarpine** (a miotic/cholinergic agonist) in the management of glaucoma is primarily due to its superior **tolerability and safety profile.** **1. Why Option C is Correct:** Pilocarpine causes significant ocular side effects due to its action on the ciliary muscle and iris sphincter. These include **accommodative spasm** (leading to induced myopia), **miosis** (causing night blindness and constricted visual fields), and **brow ache**. In contrast, Timolol lowers intraocular pressure (IOP) by reducing aqueous humor production from the ciliary body without affecting pupil size or accommodation, resulting in significantly fewer ocular side effects. **2. Why Other Options are Incorrect:** * **Option A:** While Timolol is highly effective, the primary reason for its preference is not necessarily a greater magnitude of IOP reduction, but rather the lack of vision-disrupting side effects seen with miotics. * **Option B:** Timolol works by **decreasing aqueous production**. It does not enhance uveoscleral outflow (that is the mechanism of Prostaglandin analogues like Latanoprost). * **Option D:** Timolol has significant **systemic contraindications**. Due to systemic absorption, it can cause bronchospasm and bradycardia; thus, it is contraindicated in patients with **Asthma, COPD, or Heart Block.** **Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Timolol blocks $\beta_2$ receptors in the ciliary epithelium. * **Drug of Choice:** While Timolol was historically the first line, **Prostaglandin Analogues (PGAs)** are now the current first-line treatment for Open Angle Glaucoma due to once-daily dosing and superior efficacy. * **Pilocarpine Risk:** It is a known risk factor for **Retinal Detachment** due to the tractional forces exerted on the peripheral retina during ciliary muscle contraction.

Q: Which is a recently used topical NSAID for ophthalmic use?

Nepafenac. **Explanation:** **Nepafenac** is the correct answer as it represents the newer generation of topical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). The key pharmacological concept behind Nepafenac is that it is a **prodrug**. Unlike conventional NSAIDs, Nepafenac is an amide derivative that exhibits superior intraocular penetration through the cornea. Once it reaches the iris, ciliary body, and retina, it is converted by intraocular hydrolases into **Amfenac**, a potent inhibitor of COX-1 and COX-2 enzymes. This makes it highly effective for managing pain and inflammation associated with cataract surgery and for preventing/treating **Cystoid Macular Edema (CME)**. **Analysis of Incorrect Options:** * **Indomethacin (A):** One of the oldest NSAIDs. While available in topical forms, it is less commonly used today due to a higher incidence of ocular surface irritation compared to newer agents. * **Flurbiprofen (C):** An older generation topical NSAID primarily used intraoperatively to maintain pupillary dilation (preventing miosis) during cataract surgery. * **Oxyphenbutazone (D):** An older pyrazolone derivative. It was traditionally used as an eye ointment for inflammatory conditions but has largely been phased out in modern ophthalmic practice due to the availability of more potent and safer alternatives. **High-Yield Clinical Pearls for NEET-PG:** * **Bromfenac** is another "recent" topical NSAID known for its long duration of action, allowing for **once-daily** dosing. * **Ketorolac (0.5%)** is frequently used for seasonal allergic conjunctivitis and post-operative inflammation. * **Side Effects:** Prolonged use of topical NSAIDs can lead to "corneal melting" (keratolysis), a serious complication that must be monitored. * **Indications:** Topical NSAIDs are the preferred choice over steroids when there is a risk of steroid-induced glaucoma or delayed wound healing.

Q: What is the treatment of choice for acute anterior uveitis?

Local steroids. **Explanation:** **Acute Anterior Uveitis (AAU)** is characterized by a breakdown of the blood-aqueous barrier, leading to the presence of cells and flare in the anterior chamber. The primary goal of treatment is to suppress inflammation, prevent the formation of posterior synechiae, and reduce the risk of secondary complications like glaucoma or cataracts. 1. **Why Local Steroids are the Treatment of Choice:** Topical (local) corticosteroids are the mainstay of therapy because they achieve high therapeutic concentrations directly in the anterior segment of the eye. They inhibit the arachidonic acid pathway, reducing both prostaglandins and leukotrienes. Frequent instillation (e.g., Prednisolone acetate 1% every 1–2 hours) is highly effective in controlling acute inflammation without the systemic side effects associated with oral steroids. 2. **Why Other Options are Incorrect:** * **Systemic Steroids:** These are reserved for posterior uveitis, panuveitis, or severe bilateral cases resistant to topical therapy. For simple AAU, the systemic side-effect profile outweighs the benefits. * **Local/Systemic NSAIDs:** While NSAIDs inhibit cyclooxygenase, they are significantly less potent than steroids in controlling the intense inflammatory cascade of acute uveitis. They may be used as adjuncts but are never the primary treatment of choice. **High-Yield Clinical Pearls for NEET-PG:** * **The "Mydriatic-Cycloplegic" Duo:** Always use topical steroids in conjunction with cycloplegics (e.g., Atropine or Homatropine). Cycloplegics provide pain relief by relieving ciliary spasm and prevent/break posterior synechiae. * **Drug of Choice:** **Prednisolone acetate (1%)** is the most effective topical steroid due to its superior intraocular penetration. * **Steroid-Induced Glaucoma:** Always monitor intraocular pressure (IOP) during treatment, as steroids can decrease aqueous outflow.

Q: What is the drug of choice for acute iridocyclitis?

Steroids. **Explanation:** **Acute Iridocyclitis** (Anterior Uveitis) is characterized by inflammation of the iris and ciliary body. The primary goals of management are to control inflammation, prevent the formation of synechiae, and reduce pain. **1. Why Steroids are the Correct Answer:** Steroids are the **mainstay of treatment** because they directly address the underlying pathophysiology: inflammation. They act by inhibiting the arachidonic acid pathway, thereby reducing capillary permeability and suppressing the exudation of inflammatory cells and proteins. In acute cases, topical steroids (e.g., Prednisolone acetate 1%) are administered frequently to prevent permanent ocular damage and vision loss. **2. Analysis of Incorrect Options:** * **B. Acetazolamide:** This is a carbonic anhydrase inhibitor used to lower Intraocular Pressure (IOP). While it may be used as an adjunct if secondary glaucoma develops, it does not treat the primary inflammatory process. * **C. Atropine:** This is a potent cycloplegic. While it is a crucial component of treatment (to provide comfort by relieving ciliary spasm and to prevent posterior synechiae), it is considered **supportive therapy**. Steroids remain the definitive "drug of choice" to halt the disease process. * **D. Antibiotics:** Most cases of acute iridocyclitis are sterile/autoimmune in nature. Antibiotics have no role unless a specific bacterial infection is identified. **Clinical Pearls for NEET-PG:** * **The "Mydriatic-Cycloplegic" of choice:** Atropine 1% ointment or drops. * **Steroid Side Effects:** Long-term topical steroid use can lead to **steroid-induced glaucoma** and **posterior subcapsular cataracts**. * **Signs of Iridocyclitis:** Ciliary congestion, aqueous flare/cells, Keratic Precipitates (KPs), and miosis. * **Important Association:** HLA-B27 is the most common systemic association with acute anterior uveitis.

Q: A 26-year-old male being treated for glaucoma complains of burning sensation in the eye, blurred vision, and dry eyes after receiving drug A. Examination confirmed corneal hypoesthesia. He has no complaints of headache, nausea, vomiting, or sweating. What drug was he likely treated with?

Timolol. The correct answer is **Timolol**, a non-selective beta-blocker commonly used as a first-line treatment for glaucoma. ### **Explanation of the Correct Answer** Timolol reduces intraocular pressure (IOP) by decreasing aqueous humor production from the ciliary body. A classic, high-yield side effect of topical beta-blockers is **corneal hypoesthesia** (reduced corneal sensitivity). This occurs due to a "membrane-stabilizing" or local anesthetic-like effect on the corneal nerves. Patients often present with symptoms of **dry eyes** and **blurred vision** because the reduced sensitivity leads to a decreased blink rate and tear film instability. The absence of headache, nausea, vomiting, or sweating helps rule out cholinergic side effects (Pilocarpine) or systemic adrenergic stimulation. ### **Why Other Options are Incorrect** * **Pilocarpine:** As a miotic (parasympathomimetic), it typically causes **miosis** (pupillary constriction), **accommodative spasm** (leading to brow ache/headache), and systemic side effects like sweating or nausea. It does not cause corneal anesthesia. * **Dipivefrin:** This is a prodrug of epinephrine. It typically causes **mydriasis** (pupillary dilation) and may lead to conjunctival hyperemia (redness) or systemic sympathetic effects like palpitations and hypertension, rather than corneal hypoesthesia. ### **NEET-PG High-Yield Pearls** * **Corneal Hypoesthesia:** Most commonly associated with **Timolol** and **Betaxolol** in ophthalmic practice. * **Contraindications for Timolol:** Always screen for **Bronchial Asthma** and **Heart Block**, as systemic absorption through the nasolacrimal duct can trigger bronchospasm or bradycardia. * **Punctal Occlusion:** Advise patients to apply pressure over the lacrimal sac for 1–2 minutes after instillation to minimize systemic absorption of beta-blockers.

Q: What is the drug of choice for acute anterior uveitis?

Atropine. **Explanation:** In the management of **acute anterior uveitis**, the primary goals are to provide symptomatic relief, prevent the formation of posterior synechiae, and reduce inflammation. **Why Atropine is the Drug of Choice (DOC):** While steroids treat the underlying inflammation, **Atropine (1% ointment or drops)** is traditionally considered the "drug of choice" or the most essential initial medication because it addresses the immediate complications of the disease. It acts as a potent **cycloplegic and mydriatic**, serving three critical functions: 1. **Ciliary Muscle Rest:** It paralyzes the ciliary muscle, relieving the painful ciliary spasms (photophobia and deep ache). 2. **Prevents Posterior Synechiae:** By keeping the pupil dilated, it prevents the iris from adhering to the anterior lens capsule. 3. **Breaks Existing Synechiae:** It helps break freshly formed adhesions. **Analysis of Other Options:** * **Topical Steroids (Option A):** These are the mainstay for controlling inflammation (reducing cells and flare), but they are usually considered the second most important step after initiating cycloplegia to prevent permanent structural damage. * **Systemic Steroids (Option C):** These are reserved for severe, bilateral, or recalcitrant cases of uveitis that do not respond to topical therapy. * **NSAIDs (Option D):** These have a limited role and are generally insufficient to manage the intense intraocular inflammation of acute uveitis. **High-Yield Clinical Pearls for NEET-PG:** * **Mydriatic of choice:** Atropine (long-acting) is preferred in acute stages; Homatropine or Cyclopentolate may be used in milder cases. * **The "D"s of Uveitis Management:** **D**ilate the pupil, **D**rop the inflammation (steroids), and **D**etect the cause. * **Complication:** If posterior synechiae form 360°, it leads to *seclusio pupillae*, causing *iris bombe* and secondary angle-closure glaucoma.

Q: Which of the following drugs does NOT cause retinal changes?

Amiodarone. **Explanation:** The correct answer is **Amiodarone**. In neuro-ophthalmology and ocular pharmacology, it is crucial to distinguish between drugs that affect the **retina** and those that affect the **cornea or optic nerve**. **1. Why Amiodarone is the correct answer:** Amiodarone is classically associated with **Vortex Keratopathy (Cornea Verticillata)**—fine, whorl-like golden-brown deposits in the basal epithelium of the **cornea**. While it can rarely cause optic neuropathy, it does **not** typically cause retinal pigmentary changes or retinal toxicity. **2. Analysis of Incorrect Options (Drugs causing Retinal changes):** * **Tamoxifen:** Used in breast cancer treatment, it causes **Tamoxifen Retinopathy**, characterized by bilateral, fine, yellow, crystalline deposits in the macula (paramacular area) and cystoid macular edema. * **Hydroxychloroquine (HCQ):** A high-yield topic. It causes **"Bull’s Eye Maculopathy"** due to the drug binding to melanin in the Retinal Pigment Epithelium (RPE). Screening with 10-2 Visual Fields and SD-OCT is mandatory for long-term users. * **Vigabatrin:** An antiepileptic drug known for causing **permanent peripheral visual field constriction** due to localized retinal toxicity (specifically affecting the photoreceptors and ganglion cells). **Clinical Pearls for NEET-PG:** * **Cornea Verticillata Mnemonic:** "**C**hloroquine, **A**miodarone, **I**ndomethacin, **T**amoxifen" (**CAIT**) and **Fabry’s disease**. * **Bull’s Eye Maculopathy Differential:** HCQ toxicity, Stargardt’s disease, Cone-Rod dystrophy, and Benign Concentric Macular Dystrophy. * **Thioridazine & Chlorpromazine:** Other psychiatric drugs that cause pigmentary retinopathy (salt and pepper appearance).

Q: Ganciclovir is used intravitreally for the treatment of?

Cytomegalovirus (CMV) retinitis. **Explanation:** **Correct Answer: D. Cytomegalovirus (CMV) retinitis** **Mechanism and Clinical Use:** Ganciclovir is a potent antiviral agent that acts as a nucleoside analogue, specifically inhibiting viral DNA polymerase. While it has activity against several herpesviruses, its primary clinical indication in ophthalmology is the treatment of **Cytomegalovirus (CMV) retinitis**, a sight-threatening opportunistic infection typically seen in immunocompromised patients (e.g., those with AIDS or post-organ transplant). Intravitreal administration (via injection or the Ganciclovir implant) is preferred because it achieves high therapeutic concentrations directly at the retina, bypassing the systemic side effects (like bone marrow suppression) associated with intravenous delivery. **Analysis of Incorrect Options:** * **A & B (Influenza and Rhinovirus):** These are RNA viruses. Ganciclovir is specifically an anti-DNA virus medication and has no efficacy against respiratory viruses like Influenza or Rhinovirus. * **C (Herpes Zoster Virus):** While Ganciclovir has some activity against HZV, it is not the drug of choice. HZV-related conditions (like Herpes Zoster Ophthalmicus) are primarily treated with **Acyclovir, Valacyclovir, or Famciclovir**. **High-Yield NEET-PG Pearls:** * **DOC for CMV Retinitis:** Valganciclovir (oral) or Ganciclovir (IV/Intravitreal). Foscarnet and Cidofovir are second-line agents. * **Classic Appearance:** CMV retinitis presents as "Pizza-pie" or "Cottage cheese and ketchup" fundus (hemorrhage with yellow-white exudates). * **Side Effect:** The most serious systemic side effect of Ganciclovir is **neutropenia/bone marrow suppression**. * **Ganciclovir Implant:** Known as *Vitrasert*, it provides sustained release but is now less commonly used due to the efficacy of highly active antiretroviral therapy (HAART).

Question 1

What is the treatment of choice for Pars planitis?

Accepted Answer

Corticosteroid

Answer

Pilocarpine

Answer

Beta-blocker

Answer

NSAIDs

Question 2

Timolol is preferred in glaucoma over pilocarpine because:

Accepted Answer

It produces fewer ocular side effects

Answer

It is more effective than pilocarpine

Answer

It enhances uveoscleral outflow

Answer

It has no contraindications

Question 3

Which is a recently used topical NSAID for ophthalmic use?

Accepted Answer

Nepafenac

Answer

Indomethacin

Answer

Flurbiprofen

Answer

Oxyphenbutazone

Question 4

What is the treatment of choice for acute anterior uveitis?

Accepted Answer

Local steroids

Answer

Systemic steroids

Answer

Local NSAIDs

Answer

Systemic NSAIDs

Question 5

What is the drug of choice for acute iridocyclitis?

Accepted Answer

Steroids

Answer

Acetazolamide

Answer

Atropine

Answer

Antibodies

Question 6

A 26-year-old male being treated for glaucoma complains of burning sensation in the eye, blurred vision, and dry eyes after receiving drug A. Examination confirmed corneal hypoesthesia. He has no complaints of headache, nausea, vomiting, or sweating. What drug was he likely treated with?

Accepted Answer

Timolol

Answer

Pilocarpine

Answer

Dipivefrin

Answer

Dipivefrin

Question 7

What is the drug of choice for acute anterior uveitis?

Accepted Answer

Atropine

Answer

Topical steroids

Answer

Systemic steroids

Answer

NSAIDs

Question 8

Intraocular penetration of topically-instilled drugs is mainly determined by the corneal:

Accepted Answer

Epithelium

Answer

Endothelium

Answer

Stroma

Answer

Bowman's and Descemet's membrane

Question 9

Which of the following drugs does NOT cause retinal changes?

Accepted Answer

Amiodarone

Answer

Tamoxifen

Answer

Hydroxychloroquine

Answer

Vigabatrin

Question 10

Ganciclovir is used intravitreally for the treatment of?

Accepted Answer

Cytomegalovirus (CMV) retinitis

Answer

Influenza

Answer

Rhinovirus

Answer

Herpes Zoster Virus (HZV)

Ophthalmic Pharmacology — MCQs

Ophthalmic Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?